Status:
COMPLETED
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years
Lead Sponsor:
Novartis
Collaborating Sponsors:
Novartis Vaccines
Conditions:
Encephalitis, Tick-Borne
Eligibility:
All Genders
6-16 years
Phase:
PHASE4
Brief Summary
blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteers of both sexes aged \>1 years at the time of enrollment in V48P4 who participated in studies V48P4E1 and V48P4E2, and who/whose parents or legal guardians are willing to sign informed consent.
Exclusion
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT00452621
Start Date
February 1 2007
Last Update
April 23 2008
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Center 7
Aschaffenburg, Germany, 63741
2
Center 2
Bobingen, Germany, 86399
3
Center 11
Eberbach /Neckar, Germany, 69412
4
Center 4
Kaufering, Germany, 86916